Using a promiscuous inhibitor to uncover cancer drug targets

Scientists have developed a method that exploits the multitargeted nature of a chemical inhibitor to pinpoint vulnerabilities within cancer cells.

Leave a Reply

Your email address will not be published. Required fields are marked *